Preparation and Characterization of Ph Sensitive Drug Liposomes

Caoyun Ju,Can Zhang

DOI: https://doi.org/10.1007/978-3-662-49320-5_14

2021-01-01

Abstract:There are multiple physiological and pathological barriers in cancer therapy faced by anticancer drug on the route from the injection site to the final antitumor target. In order to improve the targeting efficiency and antitumor efficacy, pH-sensitive nanocarriers have attracted much interest, owing to the abnormal pH values (pH 6.0–7.0) of tumor tissues compared with normal tissues and the stronger acidic endolysosomal lumens (pH 4.5–5.5). Recently, a novel multistage responsive drug liposome based on pH variation is prepared to vanquish the series of barriers in the whole-process delivery. The zwitterionic oligopeptide liposomes (HHG2C18-L) prepared by thin-film dispersion method contain a synthetic zwitterionic oligopeptide lipid (HHG2C18), soy phosphatidylcholine (SPC), and cholesterol. HHG2C18 is an intelligent lipid with two stearyl alkane chains as a hydrophobic block, and two amino acid groups (glutamic acid and histidine) and one pH-cleavable group (hexahydrobenzoic amide) as a hydrophilic block, which simulates natural phospholipids in the structure. In this chapter, besides the synthesis of HHG2C18 and the preparation of the HHG2C18-L, multistage pH response of HHG2C18-L to the mildly acidic tumor microenvironment and the acidic intracellular compartment successively is evaluated by the determination of particle size and zeta potential according to the pH change, buffering capacity, hydrolysis of hexahydrobenzoic amide, as well as the cellular uptake and intracellular delivery. Consequently, it has been found that this smart pH sensitive drug liposome has the ability to enhance tumor cellular uptake, improve cytosol distribution, and well target mitochondria, providing a meaningful nanoplatform for cancer therapy.